1,2,3,4-四氢菲-1-酮 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "1,2,3,4-四氢菲-1-酮" in Chinese language version.

refsWebsite

Global rank Chinese rank

1books.google.com

3^rd place

8^th place

low place

low place

4^th place

5^th place

2^nd place

23^rd place

1web.archive.org

1^st place

1^st place

books.google.com

Virgil Craig Jordan. Estrogen/antiestrogen Action and Breast Cancer Therapy. Univ of Wisconsin Press. 1986: 20–. ISBN 978-0-299-10480-1.

brunel.ac.uk

bura.brunel.ac.uk

Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays. Toxicol. Lett. 2000, 115 (3): 231–8 [2023-03-12]. PMID 10814893. doi:10.1016/s0378-4274(00)00198-3. （原始内容存档于2023-03-12）.

doi.org

Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays. Toxicol. Lett. 2000, 115 (3): 231–8 [2023-03-12]. PMID 10814893. doi:10.1016/s0378-4274(00)00198-3. （原始内容存档于2023-03-12）.

nih.gov

ncbi.nlm.nih.gov

Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays. Toxicol. Lett. 2000, 115 (3): 231–8 [2023-03-12]. PMID 10814893. doi:10.1016/s0378-4274(00)00198-3. （原始内容存档于2023-03-12）.

web.archive.org

Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays. Toxicol. Lett. 2000, 115 (3): 231–8 [2023-03-12]. PMID 10814893. doi:10.1016/s0378-4274(00)00198-3. （原始内容存档于2023-03-12）.